Prevention and control of non-communicable diseases in iran: the case for Investment.
Clinical intervention
Cost; burden
Non-communicable diseases
Policy intervention
Return on investment
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
24 06 2022
24 06 2022
Historique:
received:
05
09
2021
accepted:
06
06
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Non-communicable diseases are imposing a considerable burden on Iran. This study aims to assess the Return on Investment (ROI) for implementation of Non-communicable diseases (NCDs) prevention program in Iran. Four disease groups including cardiovascular diseases, diabetes, cancer, and respiratory diseases were included in our ROI analysis. The study followed four steps: 1) Estimating the total economic burden of NCDs using the Cost-of-Illness approach. 2) Estimating the total costs of implementing clinical and preventive interventions using an ingredient based costing at delivering level and a program costing method at central level.3) Calculating health impacts and economic benefits of interventions using the impact measures of avoided incidence, avoided mortality, healthy life years (HLYs) gained, and avoided direct treatment costs. 4) Calculating the ROI for each intervention in 5- and 15- year time horizons. The total economic burden of NCDs to the Iranian economy was IRR 838.49 trillion per year (2018), which was equivalent to 5% of the country's annual Gross Domestic Product (GDP). The package of NCD will lead to 549 000 deaths averted and 2 370 000 healthy life years gained over 15 years, and, financially, Iranian economy will gain IRR 542.22 trillion over 15 years. The highest ROI was observed for the package of physical activity interventions, followed by the interventions addressing salt, tobacco package and clinical interventions. Conclusions NCDs in Iran are causing a surge in health care costs and are contributing to reduced productivity. Those actions to prevent NCDs in Iran, as well as yielding to a notable health impact, are giving a good economic return to the society. This study underscores an essential need for establishment of a national multi-sectorial NCD coordination mechanism to bring together and strengthen existing cross-agency initiatives on NCDs.
Sections du résumé
BACKGROUND
Non-communicable diseases are imposing a considerable burden on Iran. This study aims to assess the Return on Investment (ROI) for implementation of Non-communicable diseases (NCDs) prevention program in Iran.
METHODS
Four disease groups including cardiovascular diseases, diabetes, cancer, and respiratory diseases were included in our ROI analysis. The study followed four steps: 1) Estimating the total economic burden of NCDs using the Cost-of-Illness approach. 2) Estimating the total costs of implementing clinical and preventive interventions using an ingredient based costing at delivering level and a program costing method at central level.3) Calculating health impacts and economic benefits of interventions using the impact measures of avoided incidence, avoided mortality, healthy life years (HLYs) gained, and avoided direct treatment costs. 4) Calculating the ROI for each intervention in 5- and 15- year time horizons.
RESULTS
The total economic burden of NCDs to the Iranian economy was IRR 838.49 trillion per year (2018), which was equivalent to 5% of the country's annual Gross Domestic Product (GDP). The package of NCD will lead to 549 000 deaths averted and 2 370 000 healthy life years gained over 15 years, and, financially, Iranian economy will gain IRR 542.22 trillion over 15 years. The highest ROI was observed for the package of physical activity interventions, followed by the interventions addressing salt, tobacco package and clinical interventions. Conclusions NCDs in Iran are causing a surge in health care costs and are contributing to reduced productivity. Those actions to prevent NCDs in Iran, as well as yielding to a notable health impact, are giving a good economic return to the society. This study underscores an essential need for establishment of a national multi-sectorial NCD coordination mechanism to bring together and strengthen existing cross-agency initiatives on NCDs.
Identifiants
pubmed: 35739516
doi: 10.1186/s12889-022-13615-w
pii: 10.1186/s12889-022-13615-w
pmc: PMC9229124
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1248Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© 2022. The Author(s).
Références
Iran J Radiol. 2015 Sep 08;12(4):e18372
pubmed: 26715979
J Hypertens. 2018 Dec;36(12):2380-2389
pubmed: 30005027
Am J Public Health. 2016 Jan;106(1):74-8
pubmed: 26696288
Iran Red Crescent Med J. 2016 Jan 20;18(5):e23556
pubmed: 27437122
BMC Public Health. 2019 Sep 13;19(1):1266
pubmed: 31519165
Popul Health Manag. 2011 Oct;14(5):223-30
pubmed: 21506731
Lancet. 2020 Oct 17;396(10258):1285-1306
pubmed: 32679112
Lancet. 2018 May 19;391(10134):2071-2078
pubmed: 29627159
Econ Hum Biol. 2017 Aug;26:151-163
pubmed: 28410489
J Egypt Public Health Assoc. 2020 Nov 3;95(1):29
pubmed: 33140214
Lancet. 2020 Sep 26;396(10255):918-934
pubmed: 32891217
Ann Rheum Dis. 2010 Jan;69 Suppl 1:i89-91
pubmed: 19995754
Prim Health Care Res Dev. 2018 May;19(3):264-276
pubmed: 29310744
PLoS One. 2019 Oct 4;14(10):e0223412
pubmed: 31584979
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326